Company intelligence / Profile preview

Pythagoras Medical

Herzliya, Israel

Ownership: Private
Development stage: Other

Overview

Pythagoras Medical has developed the ConfidenHT System, a real-time nerve mapping platform for renal denervation (RDN) procedures to improve the efficacy and accuracy of ablating nerves implicated in resistant hypertension. The technology provides intra-arterial nerve mapping using electrical stimulation and proprietary algorithms to guide physicians, helping to identify 'hot spots' for ablation and verify procedural effectiveness.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

SyMap Medical

Beyond the preview

Go deeper on Pythagoras Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pythagoras Medical.

Explore the full profile